- CA$6.67m
- CA$16.67m
- $6.67m
- 20
- 47
- 32
- 24
Annual income statement for ARCpoint, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 19.2 | 10.9 | 6.67 |
| Cost of Revenue | |||
| Gross Profit | 12.9 | 5.91 | 1.79 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 13.5 | 18.5 | 15.4 |
| Operating Profit | 5.66 | -7.62 | -8.72 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 5.72 | -8.32 | -9.15 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 5.72 | -8.32 | -8.94 |
| Minority Interest | |||
| Net Income Before Extraordinary Items | |||
| Net Income | 5.73 | -8.04 | -8.66 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Dilution Adjustment | |||
| Diluted Net Income | 5.77 | -8.04 | -8.66 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 36.3 | -0.071 | -0.092 |